Blog

  • Doctor explains how to spot magnesium deficiency and best sources to get vital mineral safely – Life News

    Doctor explains how to spot magnesium deficiency and best sources to get vital mineral safely – Life News

    We all have been bombarded with how magnesium supplements will cure our fatigue, leg pains and more. But do we all need magnesium, and should we take magnesium over the counter without any tests? Dr Rakesh Gupta, senior consultant, internal medicine, Indraprastha Apollo Hospitals, says: “While magnesium supplements are available over-the-counter (OTC), it’s not always advisable to take them without knowing your actual need. Magnesium is an essential mineral, but unnecessary supplementation can lead to side effects such as diarrhea, abdominal cramps, and in rare cases, toxicity-especially in people with kidney problems. In many cases, a balanced diet provides sufficient magnesium. If you’re experiencing symptoms like fatigue, muscle cramps, or irregular heartbeat, it’s better to consult a healthcare professional. They may recommend a blood test to check magnesium levels or assess your symptoms and dietary intake. Self-medicating with supplements, especially in high doses, isn’t safe or effective for everyone. It’s also important to consider interactions with other medications, such as antibiotics or diuretics. In short, while magnesium is vital, supplements should not be taken casually or as a blanket solution without understanding individual needs.

    What does magnesium do in our bodies and what is the optimum source of intake?

    Magnesium plays a crucial role in over 300 biochemical reactions in the body. It supports muscle and nerve function, regulates blood pressure, helps in energy production, maintains a healthy heartbeat, and is vital for bone health. It also plays a role in mood regulation and blood sugar control. The best and safest way to meet your magnesium needs is through food. Good dietary sources include green leafy vegetables (like spinach), nuts (especially almonds and cashews), seeds, legumes, whole grains, and bananas. Dark chocolate and certain fish like mackerel also contain magnesium. The recommended dietary allowance (RDA) for adults is around 310-420 mg per day depending on age and sex. When intake is through food, the risk of excess is low, and the absorption is more balanced. Supplements may be necessary only for those with confirmed deficiency, poor diet, or absorption issues.

    What are the symptoms of magnesium deficiency and how can we check for the deficiency?

    Magnesium deficiency can be subtle at first, but over time, it may present with symptoms like muscle cramps or twitches, fatigue, numbness or tingling, mood swings, irritability, poor sleep, and irregular heartbeat. In more severe cases, deficiency can lead to low calcium or potassium levels, which can further affect nerve and muscle function. However, because only about 1% of magnesium is found in the blood, standard blood tests may not always detect low tissue levels. A better assessment includes considering symptoms, dietary intake, medical history, and sometimes specialised tests like red blood cell magnesium levels. Chronic conditions such as diabetes, gastrointestinal disorders, alcoholism, and the use of certain medications can also raise the risk of deficiency. If you suspect low magnesium, consult your doctor rather than self-diagnosing. They can recommend appropriate tests or a trial of dietary changes before jumping to supplementation.

    Who should avoid magnesium supplements?

    Certain people should be cautious of magnesium supplements unless prescribed. Those  with kidney disease are at high risk, as their kidneys may not effectively remove excess magnesium, which can lead to toxicity. Symptoms of excess magnesium include nausea, low blood pressure, irregular heartbeat, confusion, and in extreme cases, coma. People on  medications like antibiotics (especially tetracyclines and quinolones), muscle relaxants, or diuretics should also be careful, as magnesium can interact with these drugs and affect absorption or efficacy. Those with heart block or certain digestive disorders that impair magnesium absorption should not take supplements without medical guidance. Pregnant or breastfeeding women should also follow prescribed limits. Magnesium from food is generally safe for everyone, but supplementation should be tailored to individual needs and medical history. Always talk to a healthcare provider before starting any new supplement, even if it’s available OTC.

    Continue Reading

  • Envisioning The Distance Ladder In The Era Of The Habitable Worlds Observatory

    Envisioning The Distance Ladder In The Era Of The Habitable Worlds Observatory

    A comparison of state-of-the-art geometric distances that serve to anchor the distance scale and their current relative uncertainties. Additional candidate (≲1 Mpc) eclipsing binary hosts to target in future are also pictured. Current EB distances to M31 and M33 rely on early-type stars and are not precise enough to be included in H0 determination (Vilardell et al. 2010; Bonanos et al. 2006), but we expect this will improve with more sensitive moderate- to high-resolution spectroscopy capable of characterizing late-type EB systems. — astro-ph.CO

    The current state-of-the-art cosmic distance ladder requires three rungs–geometric distances, primary indicators, and Type Ia Supernovae–to achieve a 1% measurement of the Hubble constant H0.

    The Habitable Worlds Observatory will have the sensitivity and resolution to reduce this to a two-step measurement, eliminating the third rung entirely and reaching into the Hubble flow with stellar distance indicators such as Cepheid variables and the tip of the red giant branch alone.

    We discuss the requirements for a program to measure H0 to 1% with HWO here, including telescope and instrument design considerations. We also comment on the potential of HWO to measure distances to low-mass dwarf galaxies via their RR Lyrae stars.

    Gagandeep Anand, Meredith Durbin, Rachael Beaton, Joseph Jensen, Adam Riess

    Comments: Towards the Habitable Worlds Observatory: Visionary Science and Transformational Technology SCDD, to be presented at HWO2025 and submitted to Astronomical Society of the Pacific following community comments. Feedback welcomed
    Subjects: Cosmology and Nongalactic Astrophysics (astro-ph.CO); Instrumentation and Methods for Astrophysics (astro-ph.IM)
    Cite as: arXiv:2507.02056 [astro-ph.CO] (or arXiv:2507.02056v1 [astro-ph.CO] for this version)
    https://doi.org/10.48550/arXiv.2507.02056
    Focus to learn more
    Submission history
    From: Meredith Durbin
    [v1] Wed, 2 Jul 2025 18:00:32 UTC (8,789 KB)
    https://arxiv.org/abs/2507.02056
    Astrobiology

    Explorers Club Fellow, ex-NASA Space Station Payload manager/space biologist, Away Teams, Journalist, Lapsed climber, Synaesthete, Na’Vi-Jedi-Freman-Buddhist-mix, ASL, Devon Island and Everest Base Camp veteran, (he/him) 🖖🏻

    Continue Reading

  • Apple is reportedly working on a cheaper MacBook, but will it stick the landing?

    Apple is reportedly working on a cheaper MacBook, but will it stick the landing?

    This week, we heard some news from analyst Ming-Chi Kuo about Apple entering a new segment of the laptop market. The company is reportedly working on a new MacBook at a lower starting price point than the MacBook Air, and it’ll apparently pack the A18 Pro chip found in iPhone 16 Pro and iPhone 16 Pro Max.

    While a cheaper MacBook is certainly a welcome add, the question truly stands: will Apple do it properly, or will it serve as another decoy model?

    Rumor refresh

    To quickly recap, the cheaper MacBook is rumored to use a 13-inch display, pack an A18 Pro chip, and come in the same four colors as Apple’s entry-level iPad: blue, yellow, pink, and silver. It’ll enter mass production in the fourth quarter of this year, or first quarter of 2026.

    Ultimately, theres precedent for both sides. When Apple introduced the redesigned entry-level iPad in 2022, it started at $449, making it not incredibly affordable – at least compared to its predecessor at $329.

    Sure, Apple made a cheaper iPad that looked incredibly visually similar to the higher end iPad Air, but it wasn’t a particularly fantastic deal either. Especially once you consider the fact that iPad Airs regularly went on sale for $499 at the time, leaving just $50 in price difference to gain an M1 chip, a laminated display, and more. Two years later, that iPad now starts at just $349, and often goes on sale for $299 – which is far more competitive.

    What would Apple cut?

    People are generally speculating that this new entry-level MacBook will start between $699 and $799, which seems fair – depending on how Apple positions it.

    Last fall, Apple updated all of its MacBook Air models to start with 16GB of RAM, providing a potential hint at something it could cut from an A18 Pro powered MacBook: unified memory.

    I could see this entry-level MacBook retaining 8GB of RAM, which wouldn’t necessarily be too big of a loss on its own.

    However, Apple could also cut some niceties from the entry-level MacBook: an extra USB-C port, Touch ID, a Center Stage webcam, and battery capacity could all be cut.

    New MacBook: good value?

    Out of all of those cuts, I think Touch ID might be one of the harder ones to stomach for most people. That said, there is precedent for it. Apple’s base model M4 iMac does not come with a Touch ID keyboard.

    If the MacBook comes in at $699 with 8GB of RAM and all of these feature cuts, it likely wouldn’t be too bad of a bargain. $799 makes that a much tougher sell. Given all of the fluctuating tariffs, Apple might not want to price it too low from the start, so a $799 MacBook seems much more probable.

    At $799, if it comes with 8GB of RAM and cuts a plethora of key Mac features, it might not be the best value. After all, MacBook Airs tend to go on sale for around that price level. M4 MacBook Air (which starts with 16GB of unified memory) is currently on sale for $849, and just a couple days ago we saw clearance M3 MacBook Airs (also with 16GB of unified memory) for just $699.

    Another thing worth mentioning is that there’d definitely be a $50-$100 education discount on this MacBook, bringing that $699-799 starting price point down to $599, $649, $699, or $749 for students in the US.

    Wrap up

    Obviously, those deals aren’t 24/7 – but it provides a picture of what can already exist in the market. Ultimately, Apple’s biggest competitor to this cheaper MacBook will be online retailers providing discounts on older MacBook Air models.

    If Apple were to release a cheaper MacBook without cutting too many key features, I’d be pleasantly surprised. Ultimately, this MacBook is still 3-9 months away from release, so a lot is still up in air. Kuo predicts that Apple will sell 5-7 million units of this MacBook model in 2026, suggesting that Apple is confident in what’ll put out.

    What do you think of the cheaper MacBook rumor? Do you think Apple will strike a nice balance? Let us know in the comments.


    My favorite Apple accessory recommendations:

    Follow Michael: X/Twitter, Bluesky, Instagram

    FTC: We use income earning auto affiliate links. More.


    Continue Reading

  • Japan braces for more quakes, authorities dismiss doomsday hype

    Japan braces for more quakes, authorities dismiss doomsday hype



    CNN
     — 

    Japan’s government on Saturday warned of more possible strong earthquakes in waters southwest of its main islands, but urged the public not to believe unfounded predictions of a major disaster.

    Authorities on Friday evacuated some residents from remote islands close to the epicenter of a 5.5-magnitude quake off the tip of the southernmost main island of Kyushu.

    That quake on Thursday, strong enough to make standing difficult, was one of more than 1,000 tremors in the islands of Kagoshima prefecture in the past two weeks that have fueled rumors stemming from a comic book prediction that a major disaster would befall the country this month.

    “With our current scientific knowledge, it’s difficult to predict the exact time, place or scale of an earthquake,” said Ayataka Ebita, director of the Japan Meteorological Agency’s earthquake and tsunami monitoring division, after a 5.4-magnitude quake shook the area again on Saturday.

    “We ask that people base their understanding on scientific evidence,” Ebita told a press conference.

    The manga, which some have interpreted as predicting a catastrophic event on Saturday, has prompted some travelers to avoid Japan. Arrivals from Hong Kong, where the rumors have circulated widely, were down 11% in May from the same month last year, according to the latest data.

    Japan has had record visitor numbers this year, with April setting an record monthly high of 3.9 million travelers.

    Ryo Tatsuki, the artist behind the manga “The Future I Saw,” first published in 1999 and re-released in 2021, said she was “not a prophet,” in a statement issued by her publisher.

    Earthquakes are common in Japan, one of the world’s most seismically active areas. It accounts for about one-fifth of the world’s earthquakes of magnitude 6 or greater.

    Continue Reading

  • Challenge-Based Funding To Spark Origins Breakthroughs

    Challenge-Based Funding To Spark Origins Breakthroughs

    Earth’s surface is shown as it might have looked some 3.8 billion years ago, perhaps when life was just beginning, in this artist’s rendering. Illustration: NASA/JPL-Caltech/Lizbeth B. De La Torre

    Origins of life research is marred by ambiguous questions and goals, creating uncertainty about when research objectives have been achieved.

    Because of numerous unknowns and disagreements about definitions and theories, the field lacks clear markers of progress. We argue that the origins community should focus on goals that have agreed-upon meaning and can be consensually categorized as achieved or unachieved.

    The origins community needs these goals to maintain coherence amongst a federation of problems with the shared, but nebulous aspiration of understanding the origins of life. We propose a list of challenges with clear ‘Finish Lines’–explicit descriptions of what will be achieved if each goal is reached–similar to the X-prize model.

    The intent is not to impose top-down research directions, but to compel the community to coalesce around explicit problems of the highest priority, as physics, astronomy, and planetary science communities do when setting science objectives for missions and megaprojects.

    Even if the generated phenomena are not unequivocally life-like, demonstrating systems that achieve these goals will sharpen the distinction between life itself and the constellation of phenomena that co-occur with life.

    This document was originally submitted as a whitepaper to the 2025 NASA-DARES (Decadal Astrobiology Research and Exploration Strategy) call for whitepapers (https://nspires.nasaprs.com/external/solicitations/summary.do?solId={4EC1A189-E5BF-88FE-4FEF-F7D1F448FE0D}&path=&method=init).

    Cole Mathis, Harrison B. Smith

    Comments: 5 pages
    Subjects: Instrumentation and Methods for Astrophysics (astro-ph.IM); Earth and Planetary Astrophysics (astro-ph.EP)
    Cite as: arXiv:2507.00106 [astro-ph.IM] (or arXiv:2507.00106v1 [astro-ph.IM] for this version)
    https://doi.org/10.48550/arXiv.2507.00106
    Focus to learn more
    Submission history
    From: Harrison Smith
    [v1] Mon, 30 Jun 2025 16:58:10 UTC (215 KB)
    https://arxiv.org/abs/2507.00106
    Astrobiology,

    Explorers Club Fellow, ex-NASA Space Station Payload manager/space biologist, Away Teams, Journalist, Lapsed climber, Synaesthete, Na’Vi-Jedi-Freman-Buddhist-mix, ASL, Devon Island and Everest Base Camp veteran, (he/him) 🖖🏻

    Continue Reading

  • Simulation of Images of Protoplanetary Disks After Collision with Free-floating Planets

    Simulation of Images of Protoplanetary Disks After Collision with Free-floating Planets

    The color shows the product of the radiation flux at a wavelength of 3 µm and the square of the distance for the case of a prograde fall of the planet onto the disk. Model parameters: q = 5 AU, ω = 90◦ , i = 10◦ . The time moment t = 200 years from the beginning of the calculations is shown on the left, t = 290 years is shown in the center, and t = 500 years is shown on the right. The upper graphs correspond to the direction of the line of sight against the z axis, and the lower ones along the y axis. — astro-ph.EP

    Observational manifestations of disturbances in a protoplanetary disk caused by a collision with a massive planet are studied.

    It is assumed that the planet moves along a parabolic trajectory that intersects the disk plane near the star. Gas-dynamic simulation is performed using the finite volume method on a long time scale. On its basis, images of the disk observed from the pole and edge-on are constructed in the infrared and submillimeter ranges.

    A wide range of planet orbit parameters is considered. The approach of the planet was considered both prograde and retrograde with the respect to the disk rotation. Calculations have shown that in the images of the disk seen pole-on, two spiral arms can be observed in case of the prograde fall, and one with retrograde case.

    In the case of observations of a disk whose plane is inclined at a small angle to the line of sight, distortions of the disk plane can be noticeable. In addition, a gas tail is extended from the disk in the direction of the planet’s motion, which can also be identified in observations.

    Tatiana Demidova, Vitaliy Grigoryev

    Comments: 26 pages, 9 figures, 1 table, 74 references
    Subjects: Earth and Planetary Astrophysics (astro-ph.EP); Astrophysics of Galaxies (astro-ph.GA); Solar and Stellar Astrophysics (astro-ph.SR)
    MSC classes: 85-04
    ACM classes: J.2.3
    Cite as: arXiv:2506.23795 [astro-ph.EP] (or arXiv:2506.23795v1 [astro-ph.EP] for this version)
    https://doi.org/10.48550/arXiv.2506.23795
    Focus to learn more
    Journal reference: Astronomy Letters, 2024, Vol. 50, No. 10, pp. 625-637
    Related DOI:
    https://doi.org/10.1134/S1063773724700476
    Focus to learn more
    Submission history
    From: Tatiana Demidova
    [v1] Mon, 30 Jun 2025 12:37:19 UTC (2,433 KB)
    https://arxiv.org/abs/2506.23795
    Astrobiology,

    Explorers Club Fellow, ex-NASA Space Station Payload manager/space biologist, Away Teams, Journalist, Lapsed climber, Synaesthete, Na’Vi-Jedi-Freman-Buddhist-mix, ASL, Devon Island and Everest Base Camp veteran, (he/him) 🖖🏻

    Continue Reading

  • Texas Floods Fatalities; Children Missing From Summer Camp

    Texas Floods Fatalities; Children Missing From Summer Camp

    At least 32 people have died and dozens of children are missing in the Texas Hill Country after catastrophic flooding, with officials warning the casualty count will climb as forecasts call for more rain and the risk of further flash floods in the coming days.

    Among those unaccounted for were at least 27 campers from Camp Mystic, an all-girls summer camp along the Guadalupe River in Kerr County, officials said at a briefing. Storms on Saturday on the northwest fringes of the Austin metro area left at least two people dead in Travis County, with another 10 people missing.

    Continue Reading

  • Jurassic World Rebirth Opens to Huge $300M-Plus Globally

    Jurassic World Rebirth Opens to Huge $300M-Plus Globally

    The dinos have a new lease on life.

    Universal and Amblin’s Jurassic World Rebirth is coming in ahead of expectations at the Fourth of July box office to hatch a new era for the Steven Spielberg-created franchise. In North America, the holiday tentpole is on course to post an estimated five-day domestic opening of $141.2 million, including $85.4 million for the three-day weekend, according to Saturday’s estimates.

    That’s the fifth-best showing ever for the holiday, while the three-day gross would mark the fourth-biggest domestic opening of 2025 to date. That’s no small feat considering July 4 fell on a Friday this year, meaning many moviegoers were distracted by holiday outings on what’s normally a critical day for new films. To boot, the latest Jurassic World pic has received decidedly mixed reviews from both critics and audiences alike. But there’s no dismissing the power of the Jurassic brand, or the spectacle of seeing dinosaurs come to life on the big screen.

    Jurassic World Rebirth, the seventh title in the series, is roaring even louder overseas, where its estimated opening is $171.3 million.

    That puts the film’s global start at $312.5 million — the second-best of the franchise, as well as the second-best opening of the year to date, behind A Minecraft Movie.

    Heading into the holiday, the pic was eyeing a domestic opening in the $100 to $120 million range and $260 million globally. It opened on Wednesday, July 2, to get a jump on the long holiday weekend.

    Following the conclusion of the Jurassic World trilogy directed by Colin Trevorrow, Spielberg, Amblin and Universal went back to the drawing board and enlisted filmmaker Gareth Edwards (Rogue One: A Star Wars Story) to direct Rebirth from a script by original Jurassic Park screenwriter David Koepp.

    The film features an all new cast anchored by Scarlett Johansson, Mahershala Ali and Jonathan Bailey. The story follows an extraction team that races to an island research facility that factored into the original Jurassic Park (along the way, they discover a shipwrecked family). Now, the island is inhabited by the worst of the worst creatures that were left behind.

    Rupert Friend, Manuel Garcia-Rulfo, Luna Blaise, David Iacono and Audrina Miranda also star. Producers include longtime franchise stewards Frank Marshall and Patrick Crowley, with Spielberg and Denis Stewart exec producing.

    The first three Jurassic World pics all grossed north of $1 billion globally, and all opened higher than Rebirth domestically (comparisons are complicated by the fact that they were all there-day openings). At the same time, the latest film cost less to produce, or $180 million before marketing. In 2015, Jurassic World opened to a franchise-best $208.8 million, followed by $148 million for 2018’s Jurassic World: Fallen Kingdom and $145 million for 2022’s Jurassic World: Dominion, not adjusted for inflation.

    The first Jurassic Park, directed by Spielberg, opened to $47 million domestically in early June of 1993, not adjusted for inflation — a huge sum at the time.

    Also setting off fireworks at the box office is Brad Pitt’s F1: The Movie, which is now in its second weekend after opening to $57 million domestically, a stellar number for a racing film about Formula One.

    From Apple Original Films in partnership with Warner Bros., F1 is safely parked in second place domestically with an estimated $25 million to $26 million for the three days as it crosses the $100 million mark domestically (it has already cleared $200 million globally).

    Universal and DreamWorks Animation’s live-action How to Train Your Dragon, Pixar and Disney’s Elio and Sony’s 28 Years Later are expected to round out the top five domestically. Blumhouse and Atomic Monster’s ill-fated M3GAN 2.0 could fall off as much as 68 percent in its second weekend to come in seventh behind Mission: Impossible — The Final Reckoning.

    Numbers will be updated Sunday morning.

    Continue Reading

  • Male Cancer Survivors in Physically Demanding Jobs Need More Support

    Male Cancer Survivors in Physically Demanding Jobs Need More Support

    A WeCanWork study showed that men who work laborious jobs need additional support during and after cancer treatment.

    A recent study conducted by the Well-Being and Cancer at Work (WeCanWork) project showed that men who worked in physically demanding jobs needed additional well-being support during and after cancer treatment.1

    Cathy Bradley, PhD, dean of the Colorado School of Public Health and deputy director of the University of Colorado Cancer Center, was an author on this study.2 She spoke to CancerNetwork® about how these findings can be used to design future trials and support the needs of cancer survivors with physically demanding jobs.

    The median survivor age was 51.48 years, 84.0% were White, and 25.6% reported having physically demanding jobs. Additional characteristics showed that 62.7% of survivors were married, 43.4% were college graduates, 73.7% worked full time, and 67.6% had an annual household income of less than $85,000.

    The highest reported employer accommodations included allowing workers to change their start and stop time (84.2%), allowing more breaks and rest periods (73.7%), and giving shorter workdays (51.3%). However, the lowest reported employer accommodations included arranging transportation (5.3%), providing special equipment (13.2%), and providing rehabilitation services (15.8%).

    The well-being scores highlighted that patients with physically demanding jobs had poorer wages (P <.001) and satisfaction with their benefits (P = .04), less autonomy (P = .03) and flexibility with work (P = .004), and greater financial insecurity (P = .002). Additionally, they experienced more negative job attitudes (P = .0003), workplace safety concerns (P <.001), less sleep (P = .05), and less support outside of work (P = .03).

    What was the primary motivation behind initiating this study on cancer survivors and physically demanding jobs?

    It’s based on prior evidence and work that people in physically demanding jobs have a harder time returning to work [after cancer]. We know that a lot of physically demanding jobs tend to be those without paid sick leave. They may not have health insurance. They may also be smaller employers, or if it’s something like a construction company, that doesn’t have to comply with the Family Medical Leave Act, or the Americans with Disabilities Act. We felt like this was an area of investigation that had not received enough [attention]. We wanted to understand that relationship, in particular. A lot of the prior work, and a lot of its mine, has been on women with breast cancer, and they, too, report that if they’re in physically demanding jobs, it’s harder for them to go back. Just not much work had been done on men, especially those in harder labor jobs.

    What were some of the most surprising or significant findings from the study?

    If [survivors] did have health insurance, they would continue to try hard to work and keep that financial barrier between them. Particularly, if they don’t have health insurance, they could be financially at risk. If they had health insurance, they were more likely to keep working at an hour threshold where they could qualify for health insurance. If they didn’t have these benefits, they were more likely to stop working.

    It’s interesting because you wonder what sacrifices those with health insurance are making to continue to work. Maybe they have other benefits; if you work for an employer that offers health insurance, that employer may also offer accommodations or things like that. The reverse may be true. You also wonder if they’re doing it strictly for health insurance or trading off some of their health. Then, you think about people at the other end who are just leaving work because perhaps they don’t have the sick leave benefits or other things that would allow them to keep working. We just don’t know that underlying mechanism.

    How did these findings challenge or confirm existing understandings of cancer survivorship and employment?

    They challenge it in the way that we’ve started to believe that people just go back to work. We’re seeing that that isn’t necessarily the case, and that if they do, they need to have a lot of support.

    Beyond the general impact, what are some of the specific challenges identified such as lower satisfaction with wages, less job autonomy, and financial insecurity for those in these job situations?

    The challenges are around paid sick leave, being able to take time away, and accommodations. Being able to get them in physically demanding jobs may be hard. If you’re in a desk job in an organization, it might be easier to change, be more flexible, and come in at 10 AM instead of 8 AM. If you’re doing construction, you’re probably going to be on the job site around 5 AM; there aren’t a lot of alternatives. [The challenge is giving] the support that’s required for them, and to be able to give them time away from work or just to be off until they’re ready to come back.

    How has the WeCanWork project evolved from a research study to its current implementation phase?

    In studying this, we started to think about what is it that could be helpful to everybody. We’re not going to be able to get paid sick leave passed as a national policy, but what’s something that we can do? One component is to have oncology practices start thinking about referring patients to occupational medicine for assistance. That can be enormously beneficial in the sense that somebody who is in occupational medicine could sit down and work with the oncology team to understand exactly what it is that the person needs, like more time away from work. I’m thinking about women with breast cancer who have surgery, have lymphedema, and can’t lift. For somebody who’s doing physically demanding work and may only be able to put in a half day, they can negotiate on that patient’s behalf with the employer to say, “Here’s what this person needs [while being treated for] cancer.” Oncology practices have been disconnected from occupational medicine. They fill out disability forms, but that’s not the same as being able to work with that person, ensuring that they have rehabilitation, understanding their benefits, and advocating for them.

    How does the study highlight the critical need for integrated support systems that bridge the gap between oncology care and the workplace?

    Our goal is to provide evidence-based information to show that this is helpful to people, and that it helps them continue to work. If employers know they can keep a good employee, they might be more enthusiastic about [these accommodations]. I imagine insurers would be as well. Just for oncology, it’s to give them additional support. They don’t necessarily understand sick leave policies or what a person needs at work the [same] way they understand that chemotherapy slows tumor progression. They’re focused on a very different component. Our goal is to be able to show that evidence base; that it’s a worthwhile thing to do. Also, we’re trying to understand the billing [aspect]. What code could they use for the referral and to help get reimbursed?

    The investigators called for additional longitudinal studies. What specific long-term implications do you hope to explore with such studies?

    I can see, in the future, being able to study who goes back to work in the long term. How long do they stay at work? What happens when they get there? [We want] to understand that, both with men and women in a variety of different jobs. We tend to find that people who are in good jobs are okay; if they work for a big employer, and it’s a job that offers a whole array of benefits, they tend to find their way and be okay with that. What kind of things can we do to provide support for people who aren’t in that situation? Over half of Americans are employed in small businesses.

    Is there anything else you would like to highlight?

    This is just an ongoing area of inquiry that we need to spend more time with as we start to develop these new therapies to treat cancer. I’m thinking about these oral targeted agents; they have longer-term [adverse] effects, and we need to know how that affects somebody who’s employed over time, especially if they’re going to take them for a long time. It’s not just chemotherapy for 6 months and they’re [finished]. They take them to evidence of disease progression, and that could be years. We do have to keep people working because those drugs aren’t cheap. It’s an interesting dynamic, and like I said, a place for more study.

    References

    1. Schwatka NV, Dally M, Dye-Robinson A, et al. WeCanWork study: well-being of male cancer survivors working physically demanding jobs. BMC Public Health. 2025;25(1):2025. doi:10.1186/s12889-025-23147-8
    2. Zarella O. New study reveals cancer survivors in physically demanding jobs face greater challenges. News release. Colorado School of Public Health. June 23, 2025. Accessed July 1, 2025. https://tinyurl.com/4k6hmk4u

    Continue Reading

  • Tour de France 2025: Philipsen wins chaotic first stage as Evenepoel and Roglic suffer | Tour de France 2025

    Tour de France 2025: Philipsen wins chaotic first stage as Evenepoel and Roglic suffer | Tour de France 2025

    Crashes, infighting and relentless stress characterised a frantic opening stage of the 2025 Tour de France, which was won by Jasper Philipsen, of Alpecin-Deceuninck, in Lille Metropole.

    Winner of three stages in 2024, the Belgian sprinter was too quick for the Eritrean Biniam Girmay, of Intermarché Wanty, and Norway’s Søren Wærenskjold, of Uno-X Mobility, and claimed his first yellow jersey.

    Eighteen kilometres from Lille, the gusting crosswinds forced a decisive coup, as a select group, including Philipsen, moved ahead. In the front group were the favourites, Tadej Pogacar of UAE Team Emirates-XRG and Jonas Vingegaard of Visma Lease-a-bike.

    The peloton passes the Porte de Paris arch near the start of the 1st stage of the Tour de France. The monument was built by the Sun King Louis XIV to celebrate his conquest of Lille. Photograph: Anne-Christine Poujoulat/AFP/Getty Images

    Behind, there were multiple splits in the bunch, with more scrambling required by those who had lost the wheel in front of them. Among those cut adrift were the Olympic road race champion, Remco Evenepoel of Soudal Quick-Step, and Primoz Roglic of Bora Hansgrohe, five times a Grand Tour winner.

    In a chaotic opening stage, raced at breakneck speeds through incessant crosswinds, there were soon crashes, punctures and dropped riders, with many left chasing back frantically through the race convoy. Among the casualties were Filippo Ganna of Ineos Grenadiers, Visma Lease-a-bike’s Simon Yates, the Giro d’Italia winner, the former world champion Julian Alaphilippe, now with Tudor Pro Cycling, Bahrain Victorious’s French hope Lenny Martinez, and Florian Lipowitz of Bora Hansgrohe.

    The sight of first Martinez and then Yates, battling alone to rejoin the peloton, was puzzling, given their supposed protected status. Eventually all of them, apart from the stricken Ganna, who quit the race, rejoined the back of the peloton, but with frayed nerves after a typically stressful start to the Tour.

    The stage looped south-west and then headed north, through the Pas de Calais, before turning back towards Lille and skirting the Belgian border as the peloton sped towards the finish.

    The early breakaway of five riders survived 70km before the peloton reeled them in shortly before the first intermediate sprint, at La Motte au Bois, won by Jonathan Milan of Lidl-Trek from Bryan Coquard, riding for Cofidis, and Girmay.

    The subsequent lull was filled by the French duo Benjamin Thomas, a gold medallist on the track in last year’s Paris Olympics, and Matteo Vercher.

    skip past newsletter promotion

    A momentarily at ease peloton was content to give them their head on the approach to the stage’s two short climbs, the Mont Cassel and Mont Noir, as they built a lead nudging a minute.

    Matteo Vercher of Total Energies gets back on his bike after colliding with Cofidis’s Benjamin Thomas. Photograph: Benoît Tessier/Reuters

    But in a moment that seemed to epitomise the home nation’s malaise, the pair somehow managed to sabotage each other when sprinting for the climbing points at the fourth category climb to Cassel, Thomas’s rear wheel sliding across the cobbles and taking a furious Vercher down, as they crested the top of the climb.

    Continue Reading